{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:45:59Z","timestamp":1793385959792,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.brachy.2025.11.010","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:08:43Z","timestamp":1766437723000},"page":"291-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic"],"prefix":"10.1016","volume":"25","author":[{"given":"Supriya","family":"Chopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asesh","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunima","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaahid","family":"Mulani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeevanshu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Ghadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prachi","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.brachy.2025.11.010_bib0001","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: A baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.brachy.2025.11.010_bib0002","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"Singh","year":"2023","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.brachy.2025.11.010_bib0003","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): A randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2025.11.010_bib0004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.11.010_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2013.11.011","article-title":"Curative radiation therapy for locally advanced cervical cancer: Brachytherapy is NOT optional","volume":"88","author":"Tanderup","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.11.010_bib0006","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brachy.2019.02.008","article-title":"Compendium of fractionation choices for gynaecologic HDR brachytherapy: An American Brachytherapy Society Task Group Report","volume":"18","author":"Albuquerque","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.11.010_bib0007","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","volume":"78","author":"Potter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0008","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE: A multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0009","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): A multicentre prospective cohort study","volume":"22","author":"Potter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0010","article-title":"Transitioning India to advanced image based adaptive brachytherapy: A national impact analysis of upgrading National Cancer Grid cervix cancer guidelines","volume":"16","author":"Hande","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.brachy.2025.11.010_bib0011","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.radonc.2007.04.012","article-title":"Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer","volume":"83","author":"P\u00f6tter","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0012","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2014.11.045","article-title":"Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image- guided pulsed-dose rate adaptive brachytherapy","volume":"114","author":"Mazeron","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0013","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0360-3016(93)90058-4","article-title":"The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study","volume":"25","author":"Lanciano","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.11.010_bib0014","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0360-3016(95)00220-S","article-title":"Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy","volume":"32","author":"Perez","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.11.010_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brachy.2024.10.010","article-title":"Clinical outcomes of abbreviated high-dose-rate brachytherapy in locally advanced cervical cancer: Lessons from the COVID pandemic for high-dose-rate fractionation","volume":"24","author":"Chopra","year":"2025","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.11.010_bib0016","first-page":"1","article-title":"External radiation and brachytherapy resource deficit for cervical cancer in India: Call to action for treatment of all","volume":"5","author":"Chopra","year":"2019","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0017","article-title":"Prescribing, Recording and Reprting brachytherapy for cancer of the cervix. ICRU report 89","volume":"13","year":"2013","journal-title":"J ICRU"},{"key":"10.1016\/j.brachy.2025.11.010_bib0018","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.brachy.2022.10.006","article-title":"Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic","volume":"22","author":"Chopra","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.11.010_bib0019","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13014-023-02240-5","article-title":"Safety and efficacy of single insertion accelerated MR-image guided brachytherapy following chemo\u2013radiation in locally advanced cervix cancer: Modifying our EMBRACE during the COVID pandemic","volume":"18","author":"Stevens","year":"2023","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0020","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.ijrobp.2013.01.037","article-title":"Effects of treatment duration during concomitant chemoradiation therapy for cervical cancer","volume":"86","author":"Shaverdian","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.11.010_bib0021","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.radonc.2021.05.010","article-title":"IBS-GEC ES- TRO-ABS recommendations for CT based contouring in image guided adaptive brachytherapy for cervical cancer","volume":"160","author":"Mahantshetty","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0022","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO Working Group (I): Concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0023","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.ijrobp.2021.06.014","article-title":"Single application multifractionated image guided adaptive high-dose-rate brachytherapy for cervical cancer: Dosimetric and clinical outcomes","volume":"111","author":"Mahantshetty","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.11.010_bib0024","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0360-3016(94)00635-X","article-title":"The adverse effect of treatment prolongation in cervical carcinoma","volume":"32","author":"Petereit","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.11.010_bib0025","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2009.09.045","article-title":"Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors","volume":"116","author":"Nugent","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2025.11.010_bib0026","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/cncr.27652","article-title":"The effect of treatment time in locally advanced cervical cancer in the era of concurrent chemoradiotherapy","volume":"119","author":"Song","year":"2013","journal-title":"Cancer"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:40:57Z","timestamp":1772109657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125003654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538472125003654"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.11.010","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}